Quintin J. Lai - 11 Aug 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP Strat & Investor Relations
Signature
Ryan Metz as Agent for Quintin J. Lai
Issuer symbol
WST
Transactions as of
11 Aug 2023
Net transactions value
-$5,691,372
Form type
4
Filing time
15 Aug 2023, 14:50:41 UTC
Previous filing
23 Feb 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $786,322 +8,772 +48% $89.64* 27,079 11 Aug 2023 Direct
transaction WST Common Stock Options Exercise $731,921 +7,140 +26% $102.51 34,219 11 Aug 2023 Direct
transaction WST Common Stock Options Exercise $579,941 +3,348 +9.8% $173.22 37,567 11 Aug 2023 Direct
transaction WST Common Stock Options Exercise $380,715 +1,388 +3.7% $274.29 38,955 11 Aug 2023 Direct
transaction WST Common Stock Options Exercise $167,216 +453 +1.2% $369.13 39,408 11 Aug 2023 Direct
transaction WST Common Stock Sale $4,232,326 -10,725 -27% $394.62 28,683 11 Aug 2023 Direct F1
transaction WST Common Stock Sale $3,415,510 -8,635 -30% $395.54 20,048 11 Aug 2023 Direct F2
transaction WST Common Stock Sale $689,650 -1,741 -8.7% $396.12 18,307 11 Aug 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Option (Right to Buy) Options Exercise $0 -8,772 -100% $0.000000* 0 11 Aug 2023 Common Stock 8,772 $89.64 Direct F4
transaction WST Stock Options (Right to buy) Options Exercise $0 -7,140 -100% $0.000000* 0 11 Aug 2023 Common Stock 7,140 $102.51 Direct F4
transaction WST Stock Options (Right to Buy) Options Exercise $0 -3,348 -75% $0.000000 1,116 11 Aug 2023 Common Stock 3,348 $173.22 Direct F5
transaction WST Stock Options (Right to buy) Options Exercise $0 -1,388 -50% $0.000000 1,388 11 Aug 2023 Common Stock 1,388 $274.29 Direct F6
transaction WST Stock Options (Right to buy) Options Exercise $0 -453 -25% $0.000000 1,359 11 Aug 2023 Common Stock 453 $369.13 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $393.97 to $394.96, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $394.97 to $395.93, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F3 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $395.97 to $396.45, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F4 This option is fully vested.
F5 This award vests in four equal annual installments beginning on February 18, 2021.
F6 This award vests in 4 equal annual installments beginning on 2/23/2022.
F7 This award vests in four equal annual installments beginning on February 22, 2023.